{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-106359","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.368173+00:00","generated_at":"2026-05-31T05:06:47.291338+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"FibroGen directors Blaug, Cravatt, Lema resign effective Sept 30; committees reassigned","bullets":["Suzanne Blaug, Benjamin Cravatt, and Gerald Lema resign from the Board effective September 30, 2024.","Resignations are not due to any disagreement with the Company or its management.","Audit Committee now comprises Jeffrey L. Edwards (Chair), Maykin Ho, and James A. Schoeneck.","Compensation Committee: James A. Schoeneck (Chair) and Aoife Brennan; Nominating Committee: James A. Schoeneck (Chair) and Jeffrey L. Edwards."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-106359","json":"https://secwatch.observer/filing/0000950170-24-106359.json","markdown":"https://secwatch.observer/filing/0000950170-24-106359.md","text":"https://secwatch.observer/filing/0000950170-24-106359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/fgen-20240912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:06:47.291338+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"057823d951","claim":"Suzanne Blaug resigned as Director at KYNTRA BIO, INC..","evidence_excerpt":"On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"93f6e337b8","claim":"Gerald Lema resigned as Director at KYNTRA BIO, INC..","evidence_excerpt":"On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cbc273d9a4","claim":"Benjamin Cravatt resigned as Director at KYNTRA BIO, INC..","evidence_excerpt":"On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}